Levels of Plasma C-reactive protein, Albumin and Pre-Albumin in Nigerian COVID-19 Patients

Main Article Content

Ganiyu Olatunbosun Arinola
Fabian Victory Edem
Temitope Oluwagbenga Alonge

Abstract

Aim: COVID-19 is a new viral, rapidly infectious and inflammatory disease, with no treatment currently.However, no study reported combination of high sensitive C-reactive protein (a marker of inflammation), albumin and prealbumin (markers of nutritional status) in the prognosis of COVID-19 among Nigerian COVID-19 patients. We assessed plasma levels of hsCRP, albumin, prealbumin, hsCRP albumin ratio and hsCRP-prealbumin ratio in newly admitted COVID-19 patients and COVID-19 patients at discharge.
Material and Methods: Albumin, pre-albumin and C-RP levels were determined in the plasma of confirmed cases of COVID-19 recruited form one Infectious Diseases Center, Ibadan, Nigeria using ELISA. hsCRP-albumin ratio and hsCRP-prealbumin ratio were calculated. All these parameters were compared in both groups of patients and controls.
Results: hsC-RP level was significantly higher in newly admitted COVID-19 patients compared with discharged COVID-19 patients or COVID-19 free control (p<0.05). There were no significant differences in plasma levels of albumin, prealbumin, hsCRP-albumin ratio and hsCRP-prealbumin ratio in both groups of COVID-19 patients compared with control (p>0.05).The mean values of plasma hsC-RP, albumin and prealbumin in most COVID-19 patients (89%, 100% and 91% respectively) were within normal reference ranges. hsC-RP were significantly increased in newly admitted COVID-19 patients who were females, above 40 years of age and stayed above 10 days of hospital admission (p<0.05 in each case).
Conclusion: PlasmahsC-RP levelmight be a useful prognostic marker of COVID-19. Also COVID-19 in this group of patients exhibited low grade inflammation.

Downloads

Download data is not yet available.

Article Details

Section

Original Articles

How to Cite

1.
Arinola GO, Edem FV, Alonge TO. Levels of Plasma C-reactive protein, Albumin and Pre-Albumin in Nigerian COVID-19 Patients. Ann Med Res [Internet]. 2022 Jan. 24 [cited 2026 Aug. 25];29(1):0046-51. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4021

References